<DOC>
	<DOCNO>NCT02225964</DOCNO>
	<brief_summary>This study find imaging marker change law marker course disease . The final purpose provide scientific evidence new prevention , diagnosis treatment Alzheimer 's disease .</brief_summary>
	<brief_title>Multi-modality MRI Study Differences Conversion aMCI Patients With APOEε4 AD</brief_title>
	<detailed_description>It urgent problem field cognitive neuroscience tell conversion progression amnestic mild cognitive impairment ( aMCI ) patient Apolipoproteinε4 ( APOEε4 ) Alzheimer 's Disease ( AD ) . Based preliminary work , study special group aMCI patient APOEε4 multi-modality magnetic resonance imaging ( resting-state functional MRI , structural MRI diffusion tensor image ) longitudinally . Besides , also detect APOE genotype sample enlarge sample size . According situation conversion non-conversion difference conversion progression , analyze data inter-groups intra-groups , compare image data baseline follow-up , find prediction image marker AD optimize reliability validity .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Complaint memory loss confirm informant Cognitive impairment single multiple domain , adjust age education Normal nearnormal performance general cognitive function minimum impairment daily life activity A Clinical Dementia Rating ( CDR ) score 0.5 Failure meet criterion dementia Carrying susceptible gene APOEε4 Must able accept examination MRI , sight hear allow complete test Other disease cause cognitive impairment , thyroid disease , stroke people severe visual hearing impairment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>APOEε4</keyword>
</DOC>